One possible explanation by Cauchi and collegues [43] is that the risk for T2DM related to TCF7L2 seems to be modulated by the obesity status of an individual with stronger effects in the obese. The gene discussed is TCF7L2; the disease is obesity due to melanocortin 4 receptor deficiency.